Genetic Engineering and Biotechnology News - Novel Sequencing Technique Developed for Mitochondria
The cells energy production organelle is often taken for granted on a daily basis, supplying the cell with a pool of chemical energy molecules critical for normal metabolic function. However, this unique organelle plays major roles in signaling, differentiation, and cell death. Moreover, since it contains its own DNA, it has been frequently linked to an individuals inherited risk for diabetes, heart disease, and even cancer. Now, scientists at the Icahn School of Medicine at Mount Sinai have developed a powerful new tool they believe may assist researchers in explaining the disparity between individuals with bad health habits, some of whom get sick and those that do not. "Researchers have struggled to sequence mtDNA accurately and in a cost effective manner," explained Ravi Sachidanandam, PhD, assistant professor of oncological sciences at the Icahn School of Medicine at Mount Sinai and senior author on the current study. "The technique we have developed will allow us to identify dysfunction within mitochondria and makes mtDNA a useful biomarker as well as a potential therapeutic target in cancer and many inherited diseases." Learn more.

Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases
Mount Sinai Researchers Discover New Way Cells Control RNA Production
Apr 21, 2025 View All Press Releases
Study Reveals How Inherited Genes Help Shape the Course of Cancer
Apr 14, 2025 View All Press Releases
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases